Breaking News
May 29, 2025 - Hamas Rejects Ceasefire Proposal in Gaza Strip, Disagreement Over Terms May 29, 2025 - Spanish Man Arrested for Secretly Filming Women for Expensive 'Seduction Course' May 29, 2025 - Netanyahu Accepts New Ceasefire Proposal in Gaza Strip May 29, 2025 - US Court Blocks Trump's Import Tariffs, Financial Markets React Positively May 29, 2025 - Fear of Flooding After Swiss Glacier Collapse in Blatten: One Person (64) Still Missing May 29, 2025 - Real Madrid Interested in Arsenal's Lewis-Skelly, Liverpool Pursues Ekitike May 29, 2025 - Paris Saint-Germain's Transformation: From Superstars to Team Unity May 29, 2025 - Liam Delap Chooses Chelsea Over Man United in £30M Deal May 29, 2025 - Al Nassr Aims to Extend Cristiano Ronaldo's Contract Amidst Competition May 29, 2025 - Amad Diallo Hopes Alejandro Garnacho Will Stay at Manchester United
  • HotRecentNews.com
  • World
  • Politics
  • Sports
  • Entertainment
  • Science
  • Technology
  • Health
  • Columbus
HotRecentNews.com
Menu
  • World

  • Politics

  • Sports

  • Entertainment

  • Science

  • Technology

  • Health

  • Columbus

Home / World / FDA Approves Esketamine Nasal Spray for Depression Treatment

FDA Approves Esketamine Nasal Spray for Depression Treatment

FDA Approves Esketamine Nasal Spray for Depression Treatment
No Comments 13
Facebook X
World January 21, 2025 17:07

united states - The FDA has approved the standalone use of Spravato nasal spray for severe and hard-to-treat depression in adults.

Breakthrough in Depression Treatment

Janssen's esketamine nasal spray, a relative of the anesthetic and drug ketamine, has received recognition as a solo treatment for difficult depression cases in the U.S. market since 2019. Previously used in combination with antidepressants, the FDA greenlights Spravato for standalone use. This marks a milestone as the first standalone therapy for persistent depression, potentially making it a blockbuster drug with reported earnings of $780 million in the first nine months of 2024.

While patients can still use Spravato alongside pills, the option for standalone usage offers flexibility, especially for individuals experiencing adverse reactions to other medications. Bill Martin, head of neuroscience at J&J, anticipates a rise in the number of patients benefiting from the nasal spray.

NEW Hamas Rejects Ceasefire Proposal in Gaza Strip, Disagreement Over Terms

Leave a comment Cancel

reload

Trending Now

  • Today
  • Yesterday
  • Month
  • Comments
  • 1

    Ángel Di María Returns to Boyhood Club Rosario Central

    May 30, 2025
  • 2

    Washington Spirit Coach in Talks for OL Lyonnes Head Coach Position

    May 30, 2025
  • 3

    Melbourne Victory vs. City: A-League Grand Final Revives Competition Hopes

    May 30, 2025
  • 4

    Liverpool's Darwin Nunez and Luis Diaz Targeted by Saudi Clubs in Transfer Rumors

    May 30, 2025
  • 1

    LaLiga Players with Bargain Release Clauses Drawing Transfer Interest

    May 29, 2025
  • 2

    Neymar to Decide on Santos Future After June 12 Deadline

    May 29, 2025
  • 3

    Elon Musk's 'First Buddy' Adventures Come to an End in Washington

    May 29, 2025
  • 4

    José Riveiro Appointed as Al Ahly Head Coach After Orlando Pirates Departure

    May 29, 2025
  • 5

    Roma and Sinti Gather in France to Honor 'Black Sara' Without Jan, the Dutch 'Gypsy'

    May 29, 2025
  • 1

    Tourist Impaled by Railing After Climbing Over Fence at Colosseum

    May 4, 2025
  • 2

    Mystery of 'Lost German Girl' Persists Eighty Years Later

    May 7, 2025
  • 3

    Ukrainian War Survivors Featured in Playboy: Embracing Beauty and Resilience

    May 9, 2025
  • 4

    Former Putin Advisor Accidentally Reveals Russian Military Losses in Ukraine War

    May 22, 2025
  • 5

    Gigantic 'Bird-Like Object' Spotted Near the Sun by Russian Astronomers

    May 26, 2025
Hot Recent News
The HOTRECENTNEWS.com is not responsible for the content of external sites.

SEARCH

  • World News

Back to Top